glp-1 inflammation reduction drugs calm beyond diabetes and weight loss Antiinflammatory actions of glucagon-like peptide-1–based

The report noted that individuals with clinical obesity should receive timely, evidence-based treatment to improve or remit symptoms and prevent further complications

your result depends on dose tolerance, adherence, and what you build around the medication

Archives of Dermatology , 129(3), 356363

A 10-year follow-up study

Practically: Strong recommendation to pursue: CME in obesity medicine (60+ hours for ABOM certification) Obesity Medicine Board Certification (ABOM) open to all physicians including psychiatrists Specialized training for NPs through organizations like American Association of Nurse Practitioners This training: Solidifies your competency if questioned Helps you navigate complex cases safely Improves patient outcomes (obesity treatment is more than just prescribing) What are the reimbursement rates for weight management visits

GLP-1 Medications (Ozempic, Wegovy, Zepbound) and Sleep Apnea Date Published In December 2024, Zepbound became the first medication FDA-approved specifically for obstructive sleep apnea